ELVN
NASDAQ · Pharmaceuticals
Enliven Therapeutics Inc
$60.46
+0.19 (+0.32%)
Open$60.18
Previous Close$60.27
Day High$61.77
Day Low$59.73
52W High$62.32
52W Low$14.79
Volume—
Avg Volume1.34M
Market Cap4.43B
P/E Ratio—
EPS$-1.66
SectorPharmaceuticals
Analyst Ratings
Strong Buy
18 analysts
Price Target
-47.6% upside
Current
$60.46
$60.46
Target
$31.67
$31.67
$20.91
$31.67 avg
$36.06
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 263.34M | 235.73M | 210.63M |
| Net Income | 79.58M | 63.75M | 57.56M |
| Profit Margin | 30.2% | 27.0% | 27.3% |
| EBITDA | 141.73M | 119.11M | 111.32M |
| Free Cash Flow | 52.28M | 61.02M | 35.31M |
| Rev Growth | -0.5% | +12.7% | -7.4% |
| Debt/Equity | 0.42 | 0.43 | 0.43 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,185.71 | -0.52% | 41.4 | 1.11T |
| JNJ | Johnson & Johnson | $259.24 | +0.88% | 29.3 | 617.08B |
| MRK | Merck & Co. Inc. | $128.58 | +0.16% | 99.4 | 315.27B |
| PFE | Pfizer Inc. | $26.76 | +2.14% | 34.8 | 150.87B |
| BMY | Bristol-Myers Squibb Co | $64.72 | +0.89% | 14.1 | 131.10B |
| ZTS | Zoetis Inc | $72.66 | -5.97% | 12.3 | 32.39B |